At the time of writing, Guardant Health Inc [GH] stock is trading at $65.32, up 2.96%. An important factor to consider is whether the stock is rising or falling in short-term value. The GH shares have gain 4.26% over the last week, with a monthly amount glided 9.89%, and seem to be holding up well over a long-time horizon.
From an analyst’s perspective:
Guardant Health Inc [NASDAQ: GH] stock has seen the most recent analyst activity on September 25, 2025, when Wolfe Research upgraded its rating to a Outperform but kept the price target unchanged to $75 for it. On April 10, 2025, Mizuho initiated with a Outperform rating and assigned a price target of $55 on the stock. Barclays started tracking the stock assigning a Overweight rating and suggested a price target of $60 on January 23, 2025. Guggenheim upgraded its rating to a Buy but $36 remained the price target by the analyst firm on June 28, 2024.
For the past year, the stock price of Guardant Health Inc fluctuated between $20.14 and $68.00. Currently, Wall Street analysts expect the stock to reach $73.33 within the next 12 months. Guardant Health Inc [NASDAQ: GH] shares were valued at $65.32 at the most recent close of the market. An investor can expect a potential return of 12.26% based on the average GH price forecast.
Analyzing the GH fundamentals
According to Guardant Health Inc [NASDAQ:GH], the company’s sales were 828.85M for trailing twelve months, which represents an 30.95% jump. Gross Profit Margin for this corporation currently stands at 0.63% with Operating Profit Margin at -0.56%, Pretax Profit Margin comes in at -0.5%, and Net Profit Margin reading is -0.5%. To continue investigating profitability, this company’s Return on Assets is posted at -0.31, Equity is 2.19 and Total Capital is -0.42. Upon thorough examination of the company’s fundamental financial framework, it becomes apparent that the debt-to-equity ratio stands at -4.37.
Before buying any particular stock, readers tend to pay close attention to the indicators that support and create resistance. The company’s stock is currently sitting at 64.06 points at the first support level, and at 62.79 for the second support level. However, for the 1st resistance point, the stock is sitting at 66.31, and for the 2nd resistance point, it is at 67.29.
Ratios To Look Out For
It is important to note that Guardant Health Inc [NASDAQ:GH] has a current ratio of 3.71. On the other hand, the Quick Ratio is 3.35, and the Cash Ratio is 2.64. Considering the valuation of this stock, the price to sales ratio is 9.83.
Transactions by insiders
Recent insider trading involved Tariq Musa, Director, that happened on Sep 17 ’25 when 116.0 shares were sold. Director, POTTER MYRTLE S completed a deal on Sep 17 ’25 to sell 26.0 shares. Meanwhile, Director POTTER MYRTLE S bought 26.0 shares on Sep 17 ’25.
